Last reviewed · How we verify

NCT05766878

The Rehabilitation of Atrophic Jaws Using Short Implants With Different Surface Characteristics

Completed NA Last updated 19 February 2025
What this trial tests

NA trial testing implants placement in Peri-Implantation Loss in 30 participants. Completed in 17 February 2025.

Timeline
9 June 2023
Primary endpoint
17 February 2025
17 February 2025

Quick facts

Lead sponsorUniversity of Foggia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingtriple
Primary purposetreatment
Enrollment30
Start date9 June 2023
Primary completion17 February 2025
Estimated completion17 February 2025
Sites3 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Foggia

Who can join

18 and older, any sex, with Peri-Implantation Loss or Periodontal Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the research is to evaluate the clinical outcome of short dental implants, characterized by a new macro-structural design and inserted in the upper or lower jaw in patients with reduced bone volume. The clinical outcomes will be compared for different surface treatments of implant neck and those of prosthetic components.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Influence of Implant Surface Modification on Marginal Bone Loss and Periodontal Health: A Cross-Over Randomized Clinical Trial.
    Longhi B, Pera F, Menini M, Bagnasco F, et al · · 2025 · PMID 41059354 · DOI 10.1155/ijod/8889144

Verify or expand the search:

Other University of Foggia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05766878.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing